Supplemental Disclosures (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following (in thousands):

	As of December 31,
	2023		2022
Net cost reimbursement due from collaborators	$	17,745	$	6,294
Accrued interest on investments		1,551		2,210
Other		1,107		848
	$	20,403	$	9,352

Schedules of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of December 31,
	2023		2022
Accrued personnel costs	$	18,146	$	18,071
Accrued sublicense fees and royalties		14,234		15,768
Accrued external research and development expenses		13,762		9,216
Accrued external general and administrative expenses		2,717		2,187
Accrued purchases of property and equipment		386		806
Other accrued expenses and current liabilities		458		746
	$	49,703	$	46,794